Efficacy of different antibiotics in treatment of children with respiratory mycoplasma infection  

作　　者：Mei-Ying Zhang Yan Zhao Jin-Feng Liu Guo-Ping Liu Rui-Yun Zhang Li-Min Wang 

机构地区：[1]Department of Pediatrics,Qingdao Municipal Hospital,Qingdao 266011,Shandong Province,China [2]Department of ICU,Jinan City People’s Hospital,Jinan 271199,Shandong Province,China [3]Department of Interventional Radiology,Affiliated Hospital of Qingdao University,Qingdao 266003,Shandong Province,China

出　　处：《World Journal of Clinical Cases》2021年第23期6717-6724,共8页世界临床病例杂志

摘　　要：BACKGROUND Respiratory infections in children are common pediatric diseases caused by pathogens that invade the respiratory system.Children are considerably susceptible to Mycoplasma pneumoniae infection.There has been widespread clinical attention on treatment strategies for this disease.AIM To analyze the clinical efficacy of different antibiotics in treating pediatric respiratory mycoplasma infections.METHODS We included 106 children with a confirmed diagnosis of respiratory mycoplasma infection who were admitted to our hospital from April 2017 to July 2019 and grouped them using a random number table.Among them,53 children each received clarithromycin or erythromycin.The clinical efficacy of both drugs was evaluated and compared.We performed the multiplex polymerase chain reaction(MP-PCR)test and determined the MP-PCR negative rate in children after the end of the treatment course.We compared the incidence of toxic and side effects,including nausea,diarrhea,and abdominal pain;further,we recorded the length of hospitalization,antipyretic time,and drug costs.Additionally,we evaluated and compared the compliance of the children during treatment.RESULTS The erythromycin group showed a significantly higher total effective rate of clinical treatment than the clarithromycin group.MP-PCR test results showed that the clarithromycin group had a significantly higher MP-PCR negative rate than the erythromycin group.Moreover,children in the clarithromycin group had shorter fever time,shorter hospital stays,and lower drug costs than those in the erythromycin group.The clarithromycin group had a significantly higher overall drug adherence rate than the erythromycin group.The incidence of toxic and side effects was significantly lower in the clarithromycin group than in the erythromycin group(P<0.05).CONCLUSION Our findings indicate that clarithromycin has various advantages over erythromycin,including higher application safety,stronger mycoplasma clearance,and higher medication compliance in children;therefore,it can be act

关 键 词：CLARITHROMYCIN ERYTHROMYCIN Mycoplasma respiratory infection CHILDREN Clinical efficacy Drug compliance Toxic side effects 

分 类 号：R725.6[医药卫生—儿科]